by The biopsy devices market size was estimated at US$ 2.29 billion in 2023 it is predicted to grow at a CAGR of 7.20% from 2023 to 2032 to reach around US$ 4.29 billion by 2032.
Key Takeaways
- North America region contributed more than 34% of revenue share in 2022.
- Asia-Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
- By product, the needle-based biopsy guns segment held the largest market share of 36% in 2022.
- By product, the biopsy needles segment is anticipated to grow at a remarkable CAGR of 8.6% between 2023 and 2032.
- By end use, the hospitals segment generated over 46% of revenue share in 2022.
- By end use, the clinics segment is expected to expand at the fastest CAGR over the projected period
The biopsy devices market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global biopsy devices market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global biopsy devices market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/3612
Biopsy Devices Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 7.20% |
| Market Size in 2023 | USD 2.29 Billion |
| Market Size by 2032 | USD 4.29 Billion |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Application and By End Use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
This study covers an elaborate segmentation of the global biopsy devices market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global biopsy devices market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
Read Also: X-Ray Detectors Market Size To Attain USD 5.81 Billion By 2032
Biopsy Devices Market Players
- Medtronic plc
- Becton, Dickinson, and Company
- Hologic, Inc.
- Boston Scientific Corporation
- Olympus Corporation
- C. R. Bard, Inc. (acquired by BD)
- Cook Medical LLC
- FUJIFILM Holdings Corporation
- Mauna Kea Technologies
- Devicor Medical Products, Inc.
- Leica Biosystems Nussloch GmbH (Danaher Corporation)
- INRAD Inc.
- Argon Medical Devices, Inc. (acquired by Shandong Weigao Group Medical Polymer Company Limited)
- Scion Medical Technologies LLC
- MDxHealth SA
Segments Covered in the Report
By Application
- Needle-based Biopsy Guns
- Biopsy Guidance Systems
- Biopsy Forceps
- Biopsy Needles
By End Use
- Hospitals
- Clinics
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology acquire by analysts for assemble the global biopsy devices market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global biopsy devices market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Biopsy Devices Market
5.1. COVID-19 Landscape: Biopsy Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Biopsy Devices Market, By Application
8.1. Biopsy Devices Market Revenue and Volume, by Application, 2023-2032
8.1.1. Needle-based Biopsy Guns
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Biopsy Guidance Systems
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Biopsy Forceps
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
8.1.4. Biopsy Needles
8.1.4.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Biopsy Devices Market, By End Use
9.1. Biopsy Devices Market Revenue and Volume, by End Use, 2023-2032
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Clinics
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Biopsy Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.1.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.1.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.1.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.5.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.5.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
Chapter 11. Company Profiles
11.1. Medtronic plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson, and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hologic, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Boston Scientific Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Olympus Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. C. R. Bard, Inc. (acquired by BD)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Cook Medical LLC
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. FUJIFILM Holdings Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Mauna Kea Technologies
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Devicor Medical Products, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
